(REASON) Double-blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-l-carnitine in the Prevention of Sagopilone-induced Peripheral Neuropathy.
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Levacecarnine (Primary) ; Prednisolone; Prednisone; Sagopilone
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- Acronyms REASON
- Sponsors Bayer
- 10 Jun 2017 Biomarkers information updated
- 08 Feb 2017 New source identified and integrated (ISRCTN75009754; ISRCTN: Current Controlled Trials).
- 25 Sep 2014 New trial record